相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study
Dimitris Papaconstantinou et al.
ACTA OPHTHALMOLOGICA (2010)
Effect of Brimonidine on Retinal Ganglion Cell Survival in an Optic Nerve Crush Model
Ke Ma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Surveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years' experience
M. Q. Rahman et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies
Louis B. Cantor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy
Donald R. Nixon et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Cardiorespiratory depression and hyperglycemia after unintentional ingestion of brimonidine in a neonate
Sophie Vanhaesebrouck et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2009)
Use of novel devices for control of intraocular pressure
Don S. Minckler et al.
EXPERIMENTAL EYE RESEARCH (2009)
Brimonidine Tartrate 0.15%, Dorzolamide Hydrochloride 2%, and Brinzolamide 1% Compared as Adjunctive Therapy to Prostaglandin Analogs
Thomas E. Bournias
OPHTHALMOLOGY (2009)
An Eight-week, Multicentric, Randomized, Interventional, Open-label, Phase 4, Parallel Comparison of the Efficacy and Tolerability of the Fixed Combination of Timolol Maleate 0.5%/Brimonidine Tartrate 0.2% Versus Fixed Combination of Timolol Maleate 0.5%/Dorzolamide 2% in Patients With Elevated Intraocular Pressure
Marcelo Hatanaka et al.
JOURNAL OF GLAUCOMA (2008)
E-PTFE (Gore-Tex®) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery:: 2 year randomized clinical trial
Salvatore Cillino et al.
ACTA OPHTHALMOLOGICA (2008)
Unintentional ingestion of brimonidine antiglaucoma drops - A case report and review of the literature
Enrique Soto-Perez-de-Celis et al.
PEDIATRIC EMERGENCY CARE (2007)
Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma
A. T. Fung et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Twice-daily 0.2% brimonidine 0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension -: A 12-month randomized trial
Mark B. Sherwood et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Brimonidine and timolol fixed-combination therapy versus monotherapy: A 3-month randomized trial in patients with glaucoma or ocular hypertension
ER Craven et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2005)
A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension
B Bengtsson et al.
JOURNAL OF GLAUCOMA (2005)
24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects
AGP Konstas et al.
OPHTHALMOLOGY (2005)
The Low-Pressure Glaucoma Treatment Study (LoGTS)
T Krupin et al.
OPHTHALMOLOGY (2005)
Alphagan allergy may increase the propensity for multiple eye-drop allergy
SA Osborne et al.
EYE (2005)
Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
JT Whitson et al.
JOURNAL OF GLAUCOMA (2004)
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension
ED Sharpe et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Granulomatous anterior uveitis associated with 0.2% topical brimonidine
CA Cates et al.
EYE (2003)
Role of alpha-2 Agonists in neuroprotection
L Wheeler et al.
SURVEY OF OPHTHALMOLOGY (2003)
A 3-month comparison of efficacy and safety of brimonidine-purite 0.15% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
T Mundorf et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2003)
Twelve-month evaluation of brimonidine-purite versus brimonidine in patients with glaucoma or ocular hypertension
LJ Katz
JOURNAL OF GLAUCOMA (2002)
Safety and efficacy of brimonidine in children with glaucoma
LB Enyedi et al.
JOURNAL OF AAPOS (2001)
Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial
DA Lee et al.
JOURNAL OF GLAUCOMA (2001)
Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension
ST Simmons
CLINICAL THERAPEUTICS (2001)
Vitreous concentration of topically applied brimonidine tartrate 0.2%
AR Kent et al.
OPHTHALMOLOGY (2001)
Anterior uveitis as a side effect of topical brimonidine
DB Byles et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
Silent α2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
MA Chotani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: Year-three results
S Melamed et al.
CLINICAL THERAPEUTICS (2000)
分享论文
